Skip to Content

Nanosonics Ltd NNCSF

Morningstar Rating
$1.88 +0.03 (1.62%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NNCSF is trading at a 25% discount.
Price
$1.87
Fair Value
$7.53
Uncertainty
High
1-Star Price
$8.82
5-Star Price
$5.67
Economic Moat
Njzqmln
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NNCSF is a good fit for your portfolio.

Trading Information

Previous Close Price
$1.85
Day Range
$1.881.96
52-Week Range
$1.853.78
Bid/Ask
$1.71 / $1.84
Market Cap
$569.32 Mil
Volume/Avg
1,000 / 2,756

Key Statistics

Price/Earnings (Normalized)
54.83
Price/Sales
5.24
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nanosonics is a single-product firm and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2022, there were 29,850 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, about 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
400

Competitors

Valuation

Metric
NNCSF
COH
RMD
Price/Earnings (Normalized)
54.8373.6626.02
Price/Book Value
4.7612.875.96
Price/Sales
5.2410.735.80
Price/Cash Flow
36.0353.5921.59
Price/Earnings
NNCSF
COH
RMD

Financial Strength

Metric
NNCSF
COH
RMD
Quick Ratio
5.261.801.23
Current Ratio
6.562.573.11
Interest Coverage
12.4650.9719.71
Quick Ratio
NNCSF
COH
RMD

Profitability

Metric
NNCSF
COH
RMD
Return on Assets (Normalized)
9.04%14.09%14.83%
Return on Equity (Normalized)
11.94%20.32%24.40%
Return on Invested Capital (Normalized)
9.96%17.67%18.31%
Return on Assets
NNCSF
COH
RMD
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncFjtn$135.9 Bil
BDX
Becton Dickinson & CoTywrms$68.1 Bil
ALC
Alcon IncYdvlh$41.8 Bil
CLPBY
Coloplast A/S ADRFyx$29.5 Bil
WST
West Pharmaceutical Services IncTvlm$26.3 Bil
RMD
ResMed IncJfrzp$25.6 Bil
BAX
Baxter International IncBpykf$21.1 Bil
COO
The Cooper Companies IncYcrtlnz$18.6 Bil
HOLX
Hologic IncMpbxn$17.3 Bil
TFX
Teleflex IncTbvz$10.6 Bil

Sponsor Center